S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Pozen, Sanofi End Licensing Pact for Gastric Ulcer Therapy|
|Robbins Arroyo LLP: Sanofi (SNY) Misled Shareholders According to a Recently Filed Class Action|
|Evotec and Sanofi Enter Into Exclusive Negotiations for a Major Multi-Component Strategic Collaboration (2014/12/2)|
|Sanofi Names Chief Scientific Officer Gary Nabel as Sanofi Ebola Response Coordinator (2014/11/18)|
|Pomerantz Law Firm Announces the Filing of a Class Action Against Sanofi and Certain Officers -- SNY|
|SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Sanofi to Contact Brower Piven Before the February 2, 2015 Lead Plaintiff Deadline in Class Action Lawsuit -- SNY|
|SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Sanofi|
|Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease (2014/9/17)|
|Sanofi Pasteur Announces FDA Approval of Updated Prescribing Information for Fluzone® High-Dose Vaccine for Adults 65 and Older|
|Sanofi Pasteur Announces FDA Approval of Fluzone® Intradermal Quadrivalent (Influenza Vaccine) for Adults|
Click above to view more mutual fund data and stats for sny - Sanofi ADR.